121 related articles for article (PubMed ID: 27618304)
1. The Value of Online Algorithms to Predict T-Cell Ligands Created by Genetic Variants.
van der Lee DI; Pont MJ; Falkenburg JH; Griffioen M
PLoS One; 2016; 11(9):e0162808. PubMed ID: 27618304
[TBL] [Abstract][Full Text] [Related]
2. Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach.
Hombrink P; Hassan C; Kester MG; de Ru AH; van Bergen CA; Nijveen H; Drijfhout JW; Falkenburg JH; Heemskerk MH; van Veelen PA
J Immunol; 2013 Apr; 190(8):3869-77. PubMed ID: 23475216
[TBL] [Abstract][Full Text] [Related]
3. Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets.
Griffioen M; van Bergen CA; Falkenburg JH
Front Immunol; 2016; 7():100. PubMed ID: 27014279
[TBL] [Abstract][Full Text] [Related]
4. High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations.
Hombrink P; Hadrup SR; Bakker A; Kester MG; Falkenburg JH; von dem Borne PA; Schumacher TN; Heemskerk MH
PLoS One; 2011; 6(8):e22523. PubMed ID: 21850230
[TBL] [Abstract][Full Text] [Related]
5. Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte-Derived HLA-Ligandome Using a Reverse Immunology Approach.
Hombrink P; Hassan C; Kester MG; Jahn L; Pont MJ; de Ru AH; van Bergen CA; Griffioen M; Falkenburg JH; van Veelen PA; Heemskerk MH
Clin Cancer Res; 2015 May; 21(9):2177-86. PubMed ID: 25589627
[TBL] [Abstract][Full Text] [Related]
6. Concurrent detection of circulating minor histocompatibility antigen-specific CD8+ T cells in SCT recipients by combinatorial encoding MHC multimers.
Broen K; Greupink-Draaisma A; Woestenenk R; Schaap N; Brickner AG; Dolstra H
PLoS One; 2011; 6(6):e21266. PubMed ID: 21731686
[TBL] [Abstract][Full Text] [Related]
7. Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2.
Pont MJ; van der Lee DI; van der Meijden ED; van Bergen CA; Kester MG; Honders MW; Vermaat M; Eefting M; Marijt EW; Kielbasa SM; Hoen PA; Falkenburg JH; Griffioen M
Clin Cancer Res; 2016 Aug; 22(16):4185-96. PubMed ID: 26964570
[TBL] [Abstract][Full Text] [Related]
8. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
Larsen ME; Kornblit B; Larsen MV; Masmas TN; Nielsen M; Thiim M; Garred P; Stryhn A; Lund O; Buus S; Vindelov L
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1370-81. PubMed ID: 20353833
[TBL] [Abstract][Full Text] [Related]
9. Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens.
Fuchs KJ; van de Meent M; Honders MW; Khatri I; Kester MGD; Koster EAS; Koutsoumpli G; de Ru AH; van Bergen CAM; van Veelen PA; 't Hoen PAC; van Balen P; van den Akker EB; Veelken JH; Halkes CJM; Falkenburg JHF; Griffioen M
Blood; 2024 May; 143(18):1856-1872. PubMed ID: 38427583
[TBL] [Abstract][Full Text] [Related]
10. Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell Surface.
Bijen HM; Hassan C; Kester MGD; Janssen GMC; Hombrink P; de Ru AH; Drijfhout JW; Meiring HD; de Jong AP; Falkenburg JHF; Jimenez CR; Heemskerk MHM; van Veelen PA
Proteomics; 2018 Jun; 18(12):e1700250. PubMed ID: 29251415
[TBL] [Abstract][Full Text] [Related]
11.
Bykova NA; Malko DB; Efimov GA
Front Immunol; 2018; 9():1819. PubMed ID: 30166983
[TBL] [Abstract][Full Text] [Related]
12. Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.
Zilberberg J; Feinman R; Korngold R
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1000-7. PubMed ID: 25459643
[TBL] [Abstract][Full Text] [Related]
13. Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriers.
Oosten LE; Blokland E; Kester MG; Falkenburg JH; van Halteren AG; Goulmy E
Biol Blood Marrow Transplant; 2007 Feb; 13(2):151-63. PubMed ID: 17241921
[TBL] [Abstract][Full Text] [Related]
14. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
[TBL] [Abstract][Full Text] [Related]
15. siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice.
van der Waart AB; Fredrix H; van der Voort R; Schaap N; Hobo W; Dolstra H
Cancer Immunol Immunother; 2015 May; 64(5):645-54. PubMed ID: 25724840
[TBL] [Abstract][Full Text] [Related]
16. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
[TBL] [Abstract][Full Text] [Related]
17. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
18. High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning.
Van Bergen CA; Rutten CE; Van Der Meijden ED; Van Luxemburg-Heijs SA; Lurvink EG; Houwing-Duistermaat JJ; Kester MG; Mulder A; Willemze R; Falkenburg JH; Griffioen M
Cancer Res; 2010 Nov; 70(22):9073-83. PubMed ID: 21062987
[TBL] [Abstract][Full Text] [Related]
19. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
[TBL] [Abstract][Full Text] [Related]
20. miHA-Match: computational detection of tissue-specific minor histocompatibility antigens.
Feldhahn M; Dönnes P; Schubert B; Schilbach K; Rammensee HG; Kohlbacher O
J Immunol Methods; 2012 Dec; 386(1-2):94-100. PubMed ID: 22985828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]